The Genetics and Diagnosis of WSS

Getting a diagnosis for Woodhouse-Sakati syndrome (WSS) primarily involves compatible clinical findings and molecular genetic testing. Because WSS is an ultra-rare condition, doctors must carefully distinguish it from other disorders that look similar but have different causes ^[1][2]. While a brain MRI can be supportive, it is not required for diagnosis and may be normal.

The Genetic Blueprint: DCAF17

The root cause of WSS is a change in the DCAF17 gene. Genes are like instruction manuals for the body, and the DCAF17 gene provides instructions for making a protein that helps regulate other proteins ^[3][4].

In people with WSS, pathogenic variants in this gene disrupt its normal function ^[1][4]. WSS is an autosomal recessive condition, which means a person must inherit two mutated copies of the gene (one from each parent) to develop the syndrome ^[5]. Parents are typically “carriers” who have one mutated copy and one healthy copy, and they usually show no symptoms themselves ^[6].

Understanding Inheritance

When both parents are carriers, the odds for each pregnancy are:

• 25% chance the child will have WSS (inheriting both pathogenic variants).
• 50% chance the child will be a carrier like the parents.
• 25% chance the child will not have WSS and will not be a carrier.

A genetic counselor can discuss these risks, arrange testing for siblings, and explore reproductive options according to local practice ^[1].

The “Founder” Variant

While WSS is found globally, a specific mutation known as c.436delC is more common in families from Middle Eastern backgrounds, particularly in Saudi Arabia, Qatar, and Kuwait ^[5][7]. This is called a founder variant, meaning it has been passed down through generations within a specific population ^[5].

The Diagnostic Path

The definitive way to confirm WSS is through molecular genetic testing ^[1]. Finding a “Variant of Uncertain Significance” (VUS) or only one pathogenic variant does not by itself confirm WSS. Diagnosis requires identifying two pathogenic or likely pathogenic variants that are in trans (on opposite copies of the gene). If your doctor suspects WSS based on symptoms, they may order:

1. Targeted Sequencing: Looking specifically at the DCAF17 gene ^[8].
2. Multigene Panels: Testing many genes at once that are known to cause movement or hormone issues ^[6].
3. Whole-Exome Sequencing (WES): A broad search of all the protein-coding genes in the body to find rare or unknown mutations ^[6][9]. Deletion/duplication analysis may also be used if sequencing is negative.

Once a mutation is found, testing the parents (segregation testing) can help confirm that the variants were inherited correctly and help other family members understand their own risks ^[6][10].

Clues in the Brain: MRI Findings

Doctors often use a Magnetic Resonance Imaging (MRI) scan to look for specific patterns in the brain. It is important to know that an MRI is an adjunct tool—it may be entirely normal or non-specific, and a normal scan does not rule out WSS. In subsets of patients from small research cohorts, characteristic features have been reported ^[11][2]:

• Small Pituitary Gland: The pituitary gland is the “master gland” for hormones. In WSS, this gland is sometimes smaller than normal (hypoplasia) ^[11][12].
• Iron Accumulation: Using special “iron-sensitive” scans, doctors may see iron deposits in the basal ganglia (specifically the globus pallidus), a part of the brain that controls movement ^[11][13].
• White Matter Lesions: These are bright spots on the scan in the “white matter” of the brain, which acts like the brain’s wiring ^[11][14].

Distinguishing WSS from Similar Conditions

Because WSS involves both hormone issues and brain changes, it can be confused with other rare disorders. A correct diagnosis is vital for choosing the right management.

• NBIA Disorders: WSS can share brain-imaging findings with a group of diseases called Neurodegeneration with Brain Iron Accumulation (NBIA) ^[13]. It is often compared to PKAN (Pantothenate Kinase-Associated Neurodegeneration). However, genetic testing distinguishes them, and having brain iron does not mean you have a classic NBIA disorder ^[11][13].
• Hypogonadism-Movement Syndromes: WSS can also look like Gordon-Holmes syndrome or Boucher-Neuhäuser syndrome, both of which involve delayed puberty and movement issues ^[15][16]. Doctors use genetic testing to confirm which specific gene is involved—DCAF17 for WSS versus PNPLA6 or other genes for the different syndromes ^[15][1].